HOME >> MEDICINE >> NEWS
Emory conference to educate health professionals about 'metabolic syndrome'

An estimated 25 percent of adults over the age of 20 and close to 50 percent of adults over the age of 50 have the component risk factors that make up Metabolic Syndrome. The emerging health problem is the focus of a symposium for health professionals on Friday, May 21, hosted by the Emory University School of Medicine.

Thirteen nationally recognized experts on this increasingly common disorder will present at a daylong conference called "Metabolic Syndrome: An Obesity-Related National Epidemic---Mechanisms, Clinical Care and Future Directions. The event is CME-accredited and will include session topics on the clinical characteristics, pathogenesis and treatment of the metabolic syndrome, its associated conditions, and future research directions. It will be held from 8:00 a.m. to 5:15 p.m. in the auditorium of the Woodruff Health Sciences Center Administration Building on the Emory campus at 1440 Clifton Road.

Metabolic Syndrome, also known as Syndrome X, is a clustering of cardiovascular disease risk factors that is highly linked to obesity. It causes an increased risk of coronary heart disease, type 2 diabetes, and other diseases related to plaque buildups in artery walls, such as stroke and peripheral vascular disease. The diagnosis of the condition is based on the presence of three or more cardiovascular disease risk factors, including increased abdominal fat, pre-diabetes, high blood pressure, evidence of mild generalized inflammation, low blood levels of "good" cholesterol (HDL cholesterol) and/or high blood levels of triglycerides (circulating fats in the blood).

"The actual criteria for diagnosis of Metabolic Syndrome are still being debated by researchers," says Thomas R. Ziegler, M.D., associate professor of medicine, Department of Medicine, and director of the Emory Center for Clinical and Molecular Nutrition. "For example, some criteria include abnormalities such as a tendency for easy blood clotting and evidence of oxidative
'"/>

Contact: Tia Webster
twebste@emory.edu
404-727-5692
Emory University Health Sciences Center
13-May-2004


Page: 1 2 3

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
5. Emory researchers find race and gender gaps in treatment of heart attack
6. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
7. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
8. Emory scientists find marker for long-term immunity
9. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
10. Emory scientists link atrial fibrillation with decrease in nitrous oxide
11. Immune memory from smallpox vaccination lasts more 50 years, according to Emory research

Post Your Comments:
(Date:8/1/2014)... Cannabis use among young people has spiked, with 29.3 ... marijuana at least once and 17 percent admitting to regular ... Say ‘Yes to Life,’ volunteers from the Church of Scientology ... factual information about drugs, to help reverse this alarming trend. ... Drugs, Say ‘Yes’ to Life,” volunteers have distributed 40,000 copies ...
(Date:8/1/2014)... brain plays a central role in regulating appetite and ... in the brain,s control of food intake and body ... process has been unclear. A new study ... that PPARγ activity in a type of neuron known ... response to high-fat diet. Sabrina Diano and colleagues ...
(Date:8/1/2014)... -- The U.S. Food and Drug Administration announced on ... help fight type 2 diabetes. Jardiance (empagliflozin) ... regimens to control blood sugar levels in the overall ... Office of Drug Evaluation II in the FDA,s Center ... statement. The FDA also recommended that Jardiance be ...
(Date:8/1/2014)... 01, 2014 Summer is here, and with ... during the summer, and they can be a pain for ... to help all their customers get rid of ticks and ... 6,000 eggs in the summer, which is why they are ... tall grass and woodland areas and carry a number of ...
(Date:8/1/2014)... benefits of a cancer diagnosis may improve health outcomes ... conducted by a researcher at the University of Houston ... writing intervention is the writing instruction. Otherwise, writing is ... a journal can be therapeutic, but oftentimes we don,t ... or not," said Qian Lu, assistant professor and director ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Tis the Season for Tick Prevention 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3
(Date:7/31/2014)... SARASOTA, Fla. , July 31, 2014 ... announced today that it has initiated the development of ... ; and that it has selected Quotient Clinical, ... United Kingdom (UK) to run its early ... a Clinical Trial Application (CTA) by the end of ...
(Date:7/31/2014)... Mass. , July 31, 2014  Decision Resources ... technology market intelligence product Marketrack to now include ChinaTrack; ... device landscape in an interactive dashboard providing detailed ... procedure volumes at a hospital level. Other ... , Updated data feed: In addition to end-user surveys ...
(Date:7/31/2014)... VALLEJO, Calif. , July 31, 2014 ... announce it has been selected as the recipient of ... Foundation, which will allow the University to increase research ... is about creating state-of-the-art technology for the study of ... that enhance the diverse needs and interests of our ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Touro University California Garners Grant From Long Foundation 2
Cached News: